化学
广告
生化工程
药物发现
计算生物学
钥匙(锁)
组合化学
药品
财产(哲学)
组分(热力学)
药物开发
风险分析(工程)
铅(地质)
价值(数学)
药物靶点
管理科学
化学空间
检查表
计算机科学
亲和层析
配体效率
标识
DOI:10.1021/acs.jmedchem.5c03222
摘要
Drug discovery is a complex, multiparameter optimization process. I argue that a greater emphasis on optimizing binding affinity will accelerate drug discovery. Note that "optimizing" is not always synonymous with "maximizing". While affinity is not the only property that matters, the value of optimizing drug-receptor interactions is profound and often underappreciated. Optimizing affinity provides seven distinct benefits: achieving potent tool compounds more quickly; making compounds with increased potency; making more selective compounds; optimizing drug candidates more quickly; encouraging the pursuit of more synthetically challenging compounds; expanding chemical diversity during lead optimization; and minimizing interactions with avoid-ome targets that lead to poor ADME and tox properties. Affinity, alongside other properties, should be viewed as a key strategic component throughout the entire discovery process. A checklist of practical suggestions is offered to enable project teams to more readily achieve the benefits of affinity optimization.
科研通智能强力驱动
Strongly Powered by AbleSci AI